We retrospectively reviewed the postoperative hemorrhagic risk in patients undergoing surgery for coronary revascularization who had received platelet antiaggregants preoperatively.
A significant increase in postoperative hemorrhage and a higher percentage of reoperations for this reason was observed in the patients treated with ticlopidine. However, there were no major differences in the platelet counts among the groups compared.
ThebaultJjBlatrixCeBlanchardJfPanakEA.Effects of ticlopidine, a new platelet aggregation inhibitor, in man. Clin Pharmacol Ther1975; 18: 485–90.
2.
AshidaS.AbikoY.Inhibition of platelet aggregation by a new agent, ticlopidine. Thromb Haemost1978; 40: 542–50.
3.
Picard-FraireC.Ticlopidine hydrochloride: relation between dose, kinetics, plasma concentration and effect on platelet function. Thromb Res1983; 4: 119–28.
4.
O'BrienJREtheringtonMdShuttleworthRD.Ticlopidine. An antiplatelet drug: effects in human volunteers. Thromb Res1978; 13: 245–54.
5.
DavidJLMonfortF.HerionF.RaskinetR.Compared effects of three dose levels of ticlopidine on platelet function in normal subjects. Thromb Res1979; 14: 35–49.
6.
RoeRlBrunoJjEllisDE.Ticlopidine hydrochloride: a new anti-thrombotic drug (abstract). Clin Res1981; 29: 346.
7.
KnudsenJbGormsenJ.The effect of ticlopidine on platelet function in normal volunteers and in patients with platelet hyperaggregability in vitro. Thromb Res1979; 16: 663–71.
8.
RennerC.GuilmetD.CurtetJM.La ticlopidine en chirurgie cardiaque avec circulation extra-corporelle. Nouv Presse Med1980; 9: 3249–51.
9.
BuchananMrRiscikeJaHirshJ.Aspirin inhibits platelet function independent of the acetylation of cyclo-oxygenase. Thromb Res1982; 25: 363–73.
10.
MarguliesEhWhiteAmSherryS.Sulphinpyrazone: a review of its pharmacological properties and therapeutic use. Drugs1980; 20: 179–97.
11.
FoxKmJonathanA.SelwynAP.Effects of platelet inhibition on myocardial ischaemia. Lancet1982; 2: 727–30.
12.
ThebaultJjBlatrixC.BlanchardJfPanakEA.A possible method to control prolongations of bleeding time under antiplatelet therapy with ticlopidine. Thromb Haemost1982; 48: 6–9.
13.
Neri-SerneriGgGensiniGfFavillaS.BreshiS.AbbateR.Ticlopidine activity on platelet function in patients with enhanced platelet aggregation. A short-term crossover study. 7th International Congress on Thrombosis, Valencia, 1982, Haemostasis1982; 12: 102.
14.
KobayashiK.MaedaK.KoshikawaS.KawaguchiY.ShimizuN.NaitoC.Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis. A multicenter collaborative double blind study. Thromb Res1980; 20: 255–61.
15.
ChevigneM.DavidJLRigoP.LimetR.Effect of ticlopidine, a new platelet active drug, on saphenous vein bypass patency rates: a double blind study. 7th International Congress on Thrombosis, Valencia1982, Haemostasis1982; 12: 101.
16.
RothlinM.PflügerN.SpeiserK.GoebelN.Influence of the antiaggregant ticlopidine on the patency of aortocoronary bypass grafts. 7th International Congress on Thrombosis, Valencia, 1982, Haemostasis1982; 12: 179.
17.
BrommerEJP.The effect of ticlopidine upon platelet function, haemorrhage and post-operative thrombosis in patients undergoing suprapubic prostatectomy. J Int Med Res1981; 9: 203–10.
18.
InstalléE.GonzalezM.SchoevaerdtsJcTremourouxJ.Prevention by ticlopidine of platelet consumption during extracorporeal circulation for heart surgery and lack of effect on operative and postoperative bleeding. J Cardiovasc Pharmacol1981; 3: 1174–83.
19.
ChesebroJmClementsJpFusterV.A platelet-inhibitor-drug trial in coronary artery bypass operations: benefit of peri-operative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med1982; 307: 73–8.
20.
ChesebroJmFusterV.ElvebackL.Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med1984; 310: 209–14.
21.
GentonE.GentM.HirshJ.HarkerLA.Platelet-inhibiting drugs in the prevention of clinical thrombotic disease. N Engl J Med1975; 293: 1296–300.
22.
MayumiP.DohiS.Spinal subarachnoid hematoma after lumbar puncture in a patient receiving antiplatelet therapy. Anesth Analg1983; 62: 777–9.
